Increased Epithelial Proliferation [PE] - N0000175675

Name: Table of NDC products with increased epithelial proliferation
Creator: U.S. Food & Drug Administration
License: https://creativecommons.org/licenses/by-nc-sa/4.0/

Pharmacologic Class Information

Pharmacologic Code	N0000175675
Pharmacologic Name	Increased Epithelial Proliferation
Pharmacologic Concept	Physiologic Effects - [PE]
Pharmacologic Concept Description	This concept refers to the tissue, organ, or organ system effects of drug generic ingredients, organized into an organ system classification hierarchy, beneath the "Physiological Effects [PE]" concept.

NDC Products with Increased Epithelial Proliferation

The table contains 1 products whose active ingredient are classified under the same pharmacologic class Increased Epithelial Proliferation [PE].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	66658-113	Kepivance	Non-Proprietary Name: Palifermin	Injection, Powder, Lyophilized, For Solution	Intravenous	Swedish Orphan Biovitrum Ab (publ)	ACTIVE